Evidence map›Paper›PMID 34440297›Full record

ReviewGenes2021

The Role of Preclinical Models in Creatine Transporter Deficiency: Neurobiological Mechanisms, Biomarkers and Therapeutic Development.

Elsa Ghirardini, Francesco Calugi, Giulia Sagona, Federica Di Vetta, Martina Palma, Roberta Battini, Giovanni Cioni, Tommaso Pizzorusso, Laura Baroncelli

Open access · goldAbstract readReview
In one paragraph

Review in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Structural insights into the substrate uptake and inhibition of the human creatine transporter (hCRT).Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Rescue of myocytes and locomotion throughMolecular therapy. Methods & clinical development · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Elsa GhirardiniDepartment of Developmental Neuroscience, IRCCS Stella Maris Foundation, I-56128 Pisa, Italy.
Francesco CalugiInstitute of Neuroscience, National Research Council (CNR), I-56124 Pisa, Italy.
Giulia SagonaDepartment of Developmental Neuroscience, IRCCS Stella Maris Foundation, I-56128 Pisa, Italy.ORCID 0000-0002-4788-809X
Federica Di VettaInstitute of Neuroscience, National Research Council (CNR), I-56124 Pisa, Italy.
Martina PalmaInstitute of Neuroscience, National Research Council (CNR), I-56124 Pisa, Italy.
Roberta BattiniDepartment of Developmental Neuroscience, IRCCS Stella Maris Foundation, I-56128 Pisa, Italy.
Giovanni CioniDepartment of Developmental Neuroscience, IRCCS Stella Maris Foundation, I-56128 Pisa, Italy.
Tommaso PizzorussoInstitute of Neuroscience, National Research Council (CNR), I-56124 Pisa, Italy.ORCID 0000-0001-5614-0668
Laura BaroncelliDepartment of Developmental Neuroscience, IRCCS Stella Maris Foundation, I-56128 Pisa, Italy.ORCID 0000-0001-6739-2860
Fondazione Stella Maris · ITNational Research Council · ITUniversity of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Creatine (Cr) Transporter Deficiency (CTD) is an X-linked metabolic disorder, mostly caused by missense mutations in the

Indexed as

Disease Models, AnimalAnimalsBiomarkersBrain Diseases, Metabolic, InbornCentral Nervous SystemCreatineHumansMicePlasma Membrane Neurotransmitter Transport ProteinsRatsX-Linked Intellectual DisabilityBiomarkersCreatinePlasma Membrane Neurotransmitter Transport Proteinsanimal modelsautismcreatinecreatine transporter deficiencyepilepsyintellectual disabilitymetabolic disordersmetabolism

Identifiers

PMID34440297
PMCPMC8392480
OpenAlexW3184527037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.